Non-invasive imaging of phosphoinositide-3-kinase-catalytic-subunit-alpha (PIK3CA) promoter modulation in small animal models.
Activation of the PI3K/Akt pathway, a critical step for survival in cancer cells is often associated with decreased sensitivity to several chemotherapeutic drugs. PIK3CA gene amplification is observed in 16-24% of epithelial ovarian cancer (EOC) patients in conjunction with p53 mutations. A 900 bp l...
Main Authors: | Snehal M Gaikwad, Lata Gunjal, Anitha R Junutula, Arezoo Astanehe, Sanjiv Sam Gambhir, Pritha Ray |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3564913?pdf=render |
Similar Items
-
Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk.
by: Stevens, K, et al.
Published: (2011) -
Activated phosphoinositide 3-kinase δ syndrome caused by PIK3CD mutations: expanding the phenotype
by: Peiwei Zhao, et al.
Published: (2024-01-01) -
Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase δ
by: Swan, D, et al.
Published: (2019) -
Immunodeficiency, autoimmune thrombocytopenia and enterocolitis caused by autosomal recessive deficiency of PIK3CD-encoded phosphoinositide 3-kinase δ
by: David J. Swan, et al.
Published: (2019-10-01) -
RETRACTED: p53 Loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance
by: Bhushan Thakur, et al.
Published: (2016-10-01)